Avenira Secures $5M Loan at 12% Interest to Fund Key Projects
Avenira Limited has obtained a $5 million unsecured loan to fund key mining projects and maintain working capital while awaiting a strategic investment approval.
- A$5 million unsecured loan facility secured from MLHK Vehicle 1 Limited
- Loan carries 12% annual interest, capitalised until repayment
- Funds earmarked for Wonarah Project development and Jundee South exploration
- Directors John He and Jason He abstained from loan approval due to conflicts
- Loan supports operations pending shareholder approval of strategic investment
A Timely Financial Boost
Avenira Limited (ASX:AEV) has announced a significant funding arrangement, securing a $5 million unsecured loan facility from MLHK Vehicle 1 Limited, a private mining investment group linked to two of its directors, John He and Jason He. This injection of capital arrives at a crucial juncture as the company advances its mining projects and awaits shareholder approval for a strategic investment from Sichuan Hebang Biotechnology Corporation Limited.
Loan Terms and Governance
The loan carries an interest rate of 12% per annum, with accrued interest to be capitalised and payable upon repayment of the principal. The facility is structured with a 12-month maturity, allowing for pre-payment in minimum tranches of $2 million before the due date. Notably, John He and Jason He declared their interests and abstained from the board’s decision-making process, ensuring governance protocols were observed despite their association with the lender.
Strategic Use of Funds
The funds are earmarked to support the ongoing development of the Wonarah Project, a key asset in Avenira’s portfolio, as well as continued exploration activities at Jundee South. Additionally, the loan will bolster general working capital, providing the company with operational flexibility during this period of strategic transition. This financial maneuver underscores Avenira’s commitment to maintaining momentum in its exploration and development efforts while navigating the complexities of securing external investment.
Looking Ahead
While the loan facility provides immediate financial relief, the company’s longer-term outlook hinges on the successful approval of the strategic investment from Sichuan Hebang Biotechnology Corporation Limited. This partnership could potentially reshape Avenira’s capital structure and growth trajectory. Investors will be watching closely for updates on shareholder meetings and any subsequent developments that could impact the company’s funding and project timelines.
Bottom Line?
Avenira’s new loan facility offers breathing room but raises questions about its path to sustainable funding.
Questions in the middle?
- When will shareholder approval for the strategic investment be finalized?
- How will Avenira manage repayment of the high-interest loan within 12 months?
- What impact will the strategic investment have on Avenira’s project development plans?
